Searched for
SEMAGLUTIDE PATENT EXPIRY INDIA
India, US conclude two-day trade talksIndia and the United States concluded ministerial talks on a proposed trade agreement, aiming to finalize an initial deal before Washington...- Meet Dr. Shubha Venkatesh Iyengar, Agni missile scientist, whose tech is now being used by every international airport in IndiaPresident Murmu honored 65 individuals with Padma Awards, including scientist Dr. Shubha Venkatesh Iyengar. Her 46-year tenure at CSIR-NAL ...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- Mamata Banerjee camp steps up attack on rebel leader Ritabrata Banerjee, seeks action over woman's complaintsThe Trinamool Congress has escalated its offensive against rebel leader Ritabrata Banerjee, with a party spokesperson urging government act...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- He made cooking safe for all Indian, gave away his business patent for free: Meet Padma awardee Prestige cooker owner TT Jagganth who turned a near-bankrupt firm into one of most recognised cookwareLate industrialist T. T. Jagannathan, the visionary behind the Gasket Release System that revolutionized pressure cooker safety, will be ho...
- UAE visa expiring soon? Here's how to check your status onlineUAE immigration authorities have streamlined visa validity checks via online platforms, a crucial service amid a 30-day grace period ending...
- Bombay HC cancels 'Duphachrit' trademark, rules it deceptively similar to Abbott's 'Dupha' familyThe Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...
- Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...
- F&O Radar: Call ratio spread strategy for Bank of Baroda this weekBank of Baroda has broken out of a consolidation range with bullish technical indicators, including a weekly bullish engulfing pattern and ...
- Shares worth $26 billion can soon hit market as IPO lock-ins endApproximately $26 billion in shares from 71 recently listed companies will become available for sale as IPO lock-ins expire between June 17...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Jio enters global top 20 list in WIPO patent rankingsJio Platforms has surged into the global top 20 of WIPO's PCT rankings, a remarkable leap of 320 positions. This achievement highlights Jio...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
Load More
